Cargando…

Regionally selective cardiovascular responses to adenosine A(2A) and A(2B) receptor activation

Adenosine is a local mediator that regulates changes in the cardiovascular system via activation of four G protein‐coupled receptors (A(1), A(2A), A(2B), A(3)). Here, we have investigated the effect of A(2A) and A(2B)‐selective agonists on vasodilatation in three distinct vascular beds of the rat ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Samantha L., Wragg, Edward S., Pannucci, Patrizia, Soave, Mark, Hill, Stephen J., Woolard, Jeanette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415116/ https://www.ncbi.nlm.nih.gov/pubmed/35230706 http://dx.doi.org/10.1096/fj.202101945R

Ejemplares similares

Involvement of β‐adrenoceptors in the cardiovascular responses induced by selective adenosine A(2A) and A(2B) receptor agonists
por: Wragg, Edward S., et al.
Publicado: (2022)

COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors
por: Pannucci, Patrizia, et al.
Publicado: (2023)

Probe dependence of allosteric enhancers on the binding affinity of adenosine A(1)‐receptor agonists at rat and human A(1)‐receptors measured using NanoBRET
por: Cooper, Samantha L., et al.
Publicado: (2019)

NanoBiT Complementation to Monitor Agonist-Induced Adenosine A(1) Receptor Internalization
por: Soave, Mark, et al.
Publicado: (2019)

Monitoring haemodynamic changes in rodent models to better inform safety pharmacology: Novel insights from in vivo studies and waveform analysis
por: Van Daele, Marieke, et al.
Publicado: (2022)

The effect of two selective A(1)‐receptor agonists and the bitopic ligand VCP746 on heart rate and regional vascular conductance in conscious rats
por: Cooper, Samantha L., et al.
Publicado: (2020)

A monoclonal antibody raised against a thermo-stabilised β(1)-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of β(1)-adrenoceptors expressed in stable cell lines
por: Soave, Mark, et al.
Publicado: (2018)

Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
por: Soave, Mark, et al.
Publicado: (2016)

Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels
por: Goulding, Joëlle, et al.
Publicado: (2021)

Long‐term cardiovascular effects of vandetanib and pazopanib in normotensive rats
por: Cooper, Samantha L., et al.
Publicado: (2019)

Comparison of the ligand‐binding properties of fluorescent VEGF‐A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET
por: Peach, Chloe J., et al.
Publicado: (2019)

Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors
por: Gessi, Stefania, et al.
Publicado: (2006)

Effects of receptor tyrosine kinase inhibitors on VEGF(165)a- and VEGF(165)b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2
por: Carter, Joanne J, et al.
Publicado: (2015)

Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies
por: Soave, Mark, et al.
Publicado: (2020)

Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools
por: Singh, Sameek, et al.
Publicado: (2018)

The role of adenosine receptors and endogenous adenosine in citalopram-induced cardiovascular toxicity
por: Oransay, Kubilay, et al.
Publicado: (2014)

Biophysical Mapping of the Adenosine A(2A) Receptor
por: Zhukov, Andrei, et al.
Publicado: (2011)

Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
por: Carter, Joanne J., et al.
Publicado: (2017)

Quantitative prediction of selectivity between the A(1) and A(2A) adenosine receptors
por: Burggraaff, Lindsey, et al.
Publicado: (2020)

Novel selective β(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease
por: Baker, Jillian G., et al.
Publicado: (2017)

Tracking the A(2A) adenosine receptor
por: Thurner, Patrick, et al.
Publicado: (2010)

Functional selectivity of adenosine receptor ligands
por: Verzijl, Dennis, et al.
Publicado: (2011)

Identification of Novel Adenosine A(2A) Receptor Antagonists by Virtual Screening
por: Langmead, Christopher J., et al.
Publicado: (2012)

A(2B) Adenosine Receptor and Cancer
por: Gao, Zhan-Guo, et al.
Publicado: (2019)

Positive allosteric modulation of the adenosine A(2a) receptor attenuates inflammation
por: Welihinda, Ajith A, et al.
Publicado: (2014)

Adenosine A(2A) receptor mediates microglial process retraction
por: Orr, Anna G, et al.
Publicado: (2009)

Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101
por: Stollenwerk, Todd M., et al.
Publicado: (2021)

How Are Adenosine and Adenosine A(2A) Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
por: Mori, Akihisa, et al.
Publicado: (2021)

Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
por: Cooper, Samantha L., et al.
Publicado: (2021)

Phenotyping of Mice with Heart Specific Overexpression of A(2A)-Adenosine Receptors: Evidence for Cardioprotective Effects of A(2A)-Adenosine Receptors
por: Boknik, Peter, et al.
Publicado: (2018)

Evolutionary design of selective adenosine receptor ligands
por: van der Eelke, Horst, et al.
Publicado: (2010)

Genetic tagging of the adenosine A2A receptor reveals its heterogeneous expression in brain regions
por: Wang, Muran, et al.
Publicado: (2022)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

Exploring the Effect of Halogenation in a Series of Potent and Selective A(2B) Adenosine Receptor Antagonists
por: Prieto-Díaz, Rubén, et al.
Publicado: (2022)

Molecular Evidence of Adenosine Deaminase Linking Adenosine A(2A) Receptor and CD26 Proteins
por: Moreno, Estefanía, et al.
Publicado: (2018)

Adenosine A(3) Receptor: A Promising Therapeutic Target in Cardiovascular Disease
por: Nishat, Shamama, et al.
Publicado: (2016)

Adenosine A(2A) receptors in Parkinson’s disease treatment
por: Cieślak, Marek, et al.
Publicado: (2008)

The interactome of the A(2A) adenosine receptor in vitro and in vivo
por: Bergmayr, Christian, et al.
Publicado: (2010)

A(2A )adenosine receptor interacting partners (interactome)
por: Gsandtner, Ingrid, et al.
Publicado: (2009)

Evidence for Arrhythmogenic Effects of A(2A)-Adenosine Receptors
por: Boknik, Peter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o4au6licfh1bcqa9imt5mjuhuq